Ainos (AIMD) Stock Price, News & Analysis

Company Overview

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Key Stats

• Today's Range: $0.44 to $0.46
• 50-Day Range: $0.43 to $0.57
• 52-Week Range: $0.40 to $4.29
• Volume: 34,485 shs
• Average Volume: 879,979 shs
• Market Capitalization: $6.24 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AIMD Stock Analysis - Frequently Asked Questions

How have AIMD shares performed this year?

Ainos' stock was trading at $2.05 on January 1st, 2024. Since then, AIMD stock has decreased by 78.0% and is now trading at $0.4511.
View the best growth stocks for 2024 here.

How were Ainos' earnings last quarter?

Ainos, Inc. (NASDAQ:AIMD) posted its quarterly earnings data on Wednesday, November, 6th. The company reported ($0.33) EPS for the quarter. Ainos had a negative trailing twelve-month return on equity of 75.16% and a negative net margin of 15,348.14%.

When did Ainos' stock split?

Shares of Ainos reverse split on Thursday, December 14th 2023. The 1-5 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

When did Ainos IPO?

Ainos (AIMD) raised $3 million in an IPO on Tuesday, August 9th 2022. The company issued 800,000 shares at $4.25 per share. Maxim Group acted as the underwriter for the IPO and Brookline Capital Markets was co-manager.

How do I buy shares of Ainos?

Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Ainos own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ainos investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AIMD
• Previous Symbol: NASDAQ:AIMD
• CUSIP: N/A
• CIK: 1014763
• Web: www.ainos.com
• Phone: 858-869-2986
• Fax: 806-376-9301
• Employees: 46
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-13,770,000.00
• Net Margins: -15,348.14%
• Pretax Margin: -39,441.14%
• Return on Equity: -75.16%
• Return on Assets: -50.22%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 1.37
• Quick Ratio: 1.33

Sales & Book Value

• Annual Sales: $40,633.00
• Price / Sales: 153.64
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.23 per share
• Price / Book: 0.09

Miscellaneous

• Outstanding Shares: 13,839,000
• Free Float: 12,401,000
• Market Cap: $6.24 million
• Optionable: Not Optionable
• Beta: 1.42